Anat Fisher

796 total citations
32 papers, 451 citations indexed

About

Anat Fisher is a scholar working on Immunology, Economics and Econometrics and Pediatrics, Perinatology and Child Health. According to data from OpenAlex, Anat Fisher has authored 32 papers receiving a total of 451 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Immunology, 8 papers in Economics and Econometrics and 6 papers in Pediatrics, Perinatology and Child Health. Recurrent topics in Anat Fisher's work include Biosimilars and Bioanalytical Methods (9 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Anat Fisher is often cited by papers focused on Biosimilars and Bioanalytical Methods (9 papers), Health Systems, Economic Evaluations, Quality of Life (7 papers) and Rheumatoid Arthritis Research and Therapies (5 papers). Anat Fisher collaborates with scholars based in Canada, Germany and United States. Anat Fisher's co-authors include Colin R. Dormuth, Pierre Ernst, Kristian B. Filion, Shawn Bugden, Ken Bassett, Paul E. Ronksley, Baiju R. Shah, Lisa M. Lix, Silvia Alessi‐Severini and Éric Tremblay and has published in prestigious journals such as Annals of Internal Medicine, PLoS ONE and Cochrane Database of Systematic Reviews.

In The Last Decade

Anat Fisher

31 papers receiving 446 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anat Fisher Canada 11 186 85 65 57 55 32 451
Tilenka Thynne Australia 10 138 0.7× 56 0.7× 39 0.6× 67 1.2× 35 0.6× 24 323
R. Lyu United States 8 436 2.3× 59 0.7× 62 1.0× 86 1.5× 136 2.5× 15 719
Heli Ghandehari United States 7 126 0.7× 123 1.4× 40 0.6× 70 1.2× 64 1.2× 12 421
Bingcao Wu United States 15 148 0.8× 70 0.8× 68 1.0× 24 0.4× 117 2.1× 63 690
Dae-Suk Han South Korea 16 79 0.4× 194 2.3× 75 1.2× 28 0.5× 77 1.4× 23 749
Abdulaali R. Almutairi Saudi Arabia 11 132 0.7× 89 1.0× 72 1.1× 9 0.2× 67 1.2× 48 597
Jin Choi United States 10 93 0.5× 130 1.5× 32 0.5× 26 0.5× 40 0.7× 19 359
Alan C.H. Lee Hong Kong 9 63 0.3× 130 1.5× 68 1.0× 21 0.4× 41 0.7× 12 441
Youqun Huang China 7 59 0.3× 70 0.8× 103 1.6× 11 0.2× 66 1.2× 15 520
Josep Bonet Spain 16 117 0.6× 178 2.1× 124 1.9× 19 0.3× 72 1.3× 34 691

Countries citing papers authored by Anat Fisher

Since Specialization
Citations

This map shows the geographic impact of Anat Fisher's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anat Fisher with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anat Fisher more than expected).

Fields of papers citing papers by Anat Fisher

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anat Fisher. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anat Fisher. The network helps show where Anat Fisher may publish in the future.

Co-authorship network of co-authors of Anat Fisher

This figure shows the co-authorship network connecting the top 25 collaborators of Anat Fisher. A scholar is included among the top collaborators of Anat Fisher based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anat Fisher. Anat Fisher is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dormuth, Colin R., et al.. (2025). Patient‐Reported Adverse Drug Events on Nirmatrelvir–Ritonavir: A Prospective Observational Study of a Pharmacist‐Led Follow‐Up and Monitoring Service. JACCP JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY. 8(9). 842–849.
2.
Dormuth, Colin R., et al.. (2023). Nirmatrelvir-Ritonavir and COVID-19 Mortality and Hospitalization Among Patients With Vulnerability to COVID-19 Complications. JAMA Network Open. 6(10). e2336678–e2336678. 22 indexed citations
3.
Carney, Greg, Malcolm Maclure, David M. Patrick, et al.. (2023). A cluster randomized trial assessing the impact of personalized prescribing feedback on antibiotic prescribing for uncomplicated acute cystitis to family physicians. PLoS ONE. 18(7). e0280096–e0280096. 3 indexed citations
4.
Lix, Lisa M., Christel Renoux, Carolina Moriello, et al.. (2023). Validity of diagnoses of SARS-CoV-2 infection in Canadian administrative health data: a multiprovince, population-based cohort study. CMAJ Open. 11(5). E790–E798. 1 indexed citations
5.
6.
7.
Fisher, Anat, et al.. (2022). The Impact of Mandatory Nonmedical Switching From Originator to Biosimilar Insulin Glargine. Clinical Therapeutics. 44(7). 957–970.e12. 2 indexed citations
8.
Dormuth, Colin R., Anat Fisher, Fangyun Wu, et al.. (2021). Comparison of Pregnancy Outcomes of Patients Treated With Ondansetron vs Alternative Antiemetic Medications in a Multinational, Population-Based Cohort. JAMA Network Open. 4(4). e215329–e215329. 13 indexed citations
9.
Dormuth, Colin R., Anat Fisher, Marie Hudson, et al.. (2021). Impact of using concomitant conventional DMARDs on adherence to biologic DMARD treatment in rheumatoid arthritis: Multi-centre, population-based cohort study.. PubMed. 51(6). 1291–1299. 1 indexed citations
10.
Moriello, Carolina, J. Michael Paterson, Pascal Reynier, et al.. (2021). Off-label postpartum use of domperidone in Canada: a multidatabase cohort study. CMAJ Open. 9(2). E500–E509. 4 indexed citations
11.
Filion, Kristian B., Lisa M. Lix, Sophie Dell’Aniello, et al.. (2020). Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study. BMJ. 370. m3342–m3342. 78 indexed citations
12.
Fisher, Anat, Marie Hudson, Robert W. Platt, & Colin R. Dormuth. (2020). Tofacitinib Persistence in Patients with Rheumatoid Arthritis: A Retrospective Cohort Study. The Journal of Rheumatology. 48(1). 16–24. 10 indexed citations
13.
Ernst, Pierre, Matthew Dahl, Dan Château, et al.. (2019). <p>Comparative Effectiveness Of Fluoroquinolone Antibiotic Use In Uncomplicated Acute Exacerbations Of COPD: A Multi-Cohort Study</p>. International Journal of COPD. Volume 14. 2939–2946. 4 indexed citations
14.
Fisher, Anat, Greg Carney, Ken Bassett, Malcolm Maclure, & Colin R. Dormuth. (2019). Policy‐induced selection bias in pharmacoepidemiology: The example of coverage for Alzheimer's medications in British Columbia. Pharmacoepidemiology and Drug Safety. 28(8). 1067–1076. 5 indexed citations
15.
Daneman, Nick, Dan Château, Matthew Dahl, et al.. (2019). Fluoroquinolone use for uncomplicated urinary tract infections in women: a retrospective cohort study. Clinical Microbiology and Infection. 26(5). 613–618. 21 indexed citations
16.
Fisher, Anat, Greg Carney, Ken Bassett, & Colin R. Dormuth. (2017). Tolerability of Cholinesterase Inhibitors: A Population-Based Study of Persistence, Adherence, and Switching. Drugs & Aging. 34(3). 221–231. 17 indexed citations
17.
Fisher, Anat, Ken Bassett, Gautam Goel, et al.. (2016). Heterogeneity in Comparisons of Discontinuation of Tumor Necrosis Factor Antagonists in Rheumatoid Arthritis - A Meta-Analysis. PLoS ONE. 11(12). e0168005–e0168005. 5 indexed citations
18.
Fisher, Anat, Greg Carney, Ken Bassett, & Neena L. Chappell. (2016). Cholinesterase Inhibitor Utilization: The Impact of Provincial Drug Policy on Discontinuation. Value in Health. 19(5). 688–696. 9 indexed citations
19.
Fisher, Anat, et al.. (2014). Comparative Persistence of the TNF Antagonists in Rheumatoid Arthritis – A Population-Based Cohort Study. PLoS ONE. 9(8). e105193–e105193. 34 indexed citations
20.
Sallam, Nada A., Anat Fisher, Saeid Golbidi, & Ismail Laher. (2011). Weight and inflammation are the major determinants of vascular dysfunction in the aortae of db/db mice. Naunyn-Schmiedeberg s Archives of Pharmacology. 383(5). 483–492. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Tilenka Thynne Breakdown of academic impact, for papers by R. Lyu Breakdown of academic impact, for papers by Heli Ghandehari Breakdown of academic impact, for papers by Bingcao Wu Breakdown of academic impact, for papers by Dae-Suk Han Breakdown of academic impact, for papers by Abdulaali R. Almutairi Breakdown of academic impact, for papers by Jin Choi Breakdown of academic impact, for papers by Alan C.H. Lee Breakdown of academic impact, for papers by Youqun Huang Breakdown of academic impact, for papers by Josep Bonet
Rankless by CCL
2026